2/27
06:26 am
carl
Carlsmed (CARL) was downgraded by Zacks Research from "hold" to "strong sell".
Low
Report
Carlsmed (CARL) was downgraded by Zacks Research from "hold" to "strong sell".
2/26
02:25 am
carl
Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M [Seeking Alpha]
High
Report
Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M [Seeking Alpha]
2/26
12:28 am
carl
Carlsmed Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Carlsmed Q4 Earnings Call Highlights [Yahoo! Finance]
2/25
04:13 pm
carl
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
2/25
04:01 pm
carl
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
2/23
04:10 pm
carl
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference [Yahoo! Finance]
Low
Report
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference [Yahoo! Finance]
2/23
04:01 pm
carl
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
Low
Report
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
2/18
04:05 pm
carl
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
Medium
Report
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
2/14
01:32 am
carl
Low
Report
2/11
04:27 pm
carl
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]
Medium
Report
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]
2/11
04:01 pm
carl
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Medium
Report
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
2/10
09:00 am
carl
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
Low
Report
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
1/17
01:11 am
carl
Low
Report
1/12
08:19 am
carl
Carlsmed Reports Q4, FY 2025 revenue above estimate [Seeking Alpha]
High
Report
Carlsmed Reports Q4, FY 2025 revenue above estimate [Seeking Alpha]
1/12
08:05 am
carl
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
High
Report
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
1/9
07:00 am
carl
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
1/6
04:05 pm
carl
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
Low
Report
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
12/16
04:01 pm
carl
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
Neutral
Report
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
12/15
07:20 am
carl
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at BTIG Research.
Low
Report
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at BTIG Research.